Vaginal Pruritus Diagnosis and Treatment

Diagnostic Approach

The Centers for Disease Control and Prevention recommends obtaining microscopic confirmation using wet-mount preparation with 10% KOH to visualize yeast or pseudohyphae before initiating any treatment 1, 2, 3
Checking vaginal pH is essential, as a normal pH (≤4.5) suggests candidiasis, while pH >4.5 indicates bacterial vaginosis or trichomoniasis 1, 2

The American College of Obstetricians and Gynecologists recommends using either a single 150 mg oral dose of fluconazole or short-course topical azole therapy (1-7 days) for uncomplicated vulvovaginal candidiasis, both achieving >90% response rates 1, 2, 3
For recurrent vulvovaginal candidiasis, the guideline suggests a two-phase approach: induction therapy with 10-14 days of topical azole or oral fluconazole, followed by maintenance therapy with fluconazole 150 mg weekly for 6 months 3

In pregnant women, the guideline recommends avoiding oral fluconazole due to association with spontaneous abortion and congenital malformations, and using only topical azole therapy for 7 days 3
For HIV-positive patients, treatment regimens are identical to HIV-negative women with equivalent response rates 1, 2, 3
In elderly patients, the British Journal of Dermatology recommends starting with emollients and topical steroids for at least 2 weeks to treat asteatotic eczema, and avoiding sedating antihistamines 5

The Centers for Disease Control and Prevention advises that self-medication should only be recommended for women previously diagnosed with VVC who experience recurrence of identical symptoms 1, 2, 3
Available OTC preparations include Clotrimazole, miconazole, butoconazole, and tioconazole 1, 2

The guideline warns against assuming diagnosis without microscopic confirmation, as self-diagnosis is unreliable 3
It is essential to remember that VVC can occur concomitantly with STDs, requiring appropriate testing 1, 2, 3
Oil-based creams and suppositories may weaken latex condoms and diaphragms 2

The British Journal of Dermatology recommends referring to secondary care if diagnostic doubt exists or primary care management fails to relieve symptoms 5
Consider biopsy if diagnosis is uncertain, disease fails to respond to treatment, or neoplastic change is suspected 4, 5